Un intoppo nel punto rivela perché i modelli di sequenza del DNA sono importanti nella malattia di Huntington
Two individuals with the same CAG repeat count can have vastly different HD journeys. A new study looking at individuals with 36-42 repeats shows that DNA sequence patterns play a major role in symptom onset and progression. Read more
I vermi in soccorso: separare il buono, il cattivo e l'huntingtina grumosa
⏱️ 7 min read | A team of researchers developed a simple platform to test how toxic different types of HTT protein clumps are using a laboratory worm model. They showed that certain types of clumps are harmful to the worms, while others are not. Read more
Gennaio 2026: questo mese nella ricerca sulla malattia di Huntington
⏱️ 9 min read | January 2026 HD research recap: SKY-0515 shows promising safety data, community advocacy helps secure critical FDA meeting for AMT-130, plus new insights on sleep, vaccines, and symptom management. Read the full roundup! Read more
Annunciati i risultati della fase 1 per il farmaco SKY-0515 di Skyhawk
Skyhawk Therapeutics shared results for SKY-0515, a drug designed to lower huntingtin. The drug appeared generally safe, with 60% reduction of huntingtin in blood at the highest dose tested. This data is an encouraging step as larger trials continue. Read more
La difesa della comunità contro la malattia di Huntington aiuta a ottenere un incontro critico con la FDA per l'AMT-130
⏱️5 min read |The Huntington’s disease community’s unprecedented mobilization helped secure a high-priority FDA meeting to discuss the path forward for AMT-130. Read more
Dormire meglio, funzionare meglio: un nuovo studio collega la qualità del sonno ai risultati clinici nella malattia di Huntington
⏱️6 min read | Most people with HD report sleep problems, & new research suggests sleep quality is linked to many aspects of living with the disease. Wearables tracked people with HD for a year & revealed better sleep & strength training might help. Read more
IT 
EN 
ES 
DE 
FR